|

ACADIA PHARMACEUTICALS INC (ACAD)

US0042251084 - Common Stock

20.98  -0.81 (-3.72%)

After market: 20.98 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
631.90M517.20M484.10M441.80M339.10M
Cost Of Goods
26.20M10.20M18.00M20.60M19.60M
Gross Profit
605.80M507.10M466.10M421.20M319.50M
Operating Expenses
760.10M730.60M636.60M707.70M566.00M
Research and Development
360.60M361.60M239.40M319.10M240.40M
Selling, General, and Administrative Expenses
399.50M369.10M396.00M388.70M325.60M
Operating Income
-154.50M-223.60M-170.40M-286.60M-246.50M
Interest Income/Expense
16.10M6.60M600.00K6.60M11.20M
Other Income/Expense
6.60M3.50M2.30M-1.00M1.00M
Income Before Taxes
-131.60M-213.40M-167.50M-281.00M-234.40M
Income Tax
17.10M2.50M400.00K600.00K900.00K
Net Income
-148.80M-216.00M-167.90M-281.60M-235.30M
EBITDA
-150.09M-221.57M-167.05M-283.66M-243.73M
 
Per Share Data
EPS Diluted Total Ops
-0.92-1.34-1.05-1.79-1.60
Non GAAP EPS
-0.92-0.97-1.05-1.80-1.60
 
Statistics
Gross Profit Margin
95.87%98.05%96.28%95.34%94.22%
Profit Margin
-23.55%-41.76%-34.68%-63.74%-69.39%
Operating Profit Margin
-24.45%-43.23%-35.20%-64.87%-72.69%

All data in USD

Charts